{"schema_version":"secwatch.filing_event.v1","accession":"0001872789-24-000026","form_type":"8-K","ticker":"EMBC","cik":"0001872789","company_name":"Embecta Corp.","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.042400+00:00","generated_at":"2026-05-31T10:31:56.458997+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Embecta Q3 revenues down 4.8%; adjusted EPS up, guidance raised","bullets":["Q3 revenues $272.5M, down 4.8% YoY; U.S. down 6.7%, international down 2.5% reported.","Adjusted net income $43.0M ($0.74 diluted) vs $39.8M ($0.69) YoY; adj. EBITDA margin 36.4%.","Raised FY2024 outlook: adjusted EPS now $2.30-$2.35 (prev $2.20-$2.30), adj. gross margin 65.25%-65.50%.","Board declared $0.15 quarterly dividend, payable Sept 13, 2024 to holders of record Aug 27.","Progress on FDA 510(k) for open-loop patch pump; ~93% of global revenue now on own systems."],"urls":{"canonical":"https://secwatch.observer/filing/0001872789-24-000026","json":"https://secwatch.observer/filing/0001872789-24-000026.json","markdown":"https://secwatch.observer/filing/0001872789-24-000026.md","text":"https://secwatch.observer/filing/0001872789-24-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1872789/000187278924000026/0001872789-24-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1872789/000187278924000026/embc-20240809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:31:56.458997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}